Up a level |
Jabbour, E. y Martinelli, G. y Vignetti, M. y Kantarjian, Hagop M. y Gómez Almaguer, David y Minami, Y. y Dombret, H. y Hennessy, M. y Vorog, A. y Wang, B. y Ribera, J. M. (2022) PB1762: ponatinib versus imatinib with reduced-intensity chemotherapy in patients with newly diagnosed philadelphia chromosome–positive (ph+) acute lymphoblastic leukemia (all): phallcon study. HemaSphere, 6. pp. 1643-1644. ISSN 2572-9241